Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center

Restricted access

Harrys A. Torres, MD, is an Associate Professor of Medicine in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas, where he is also founder and director of the Hepatitis C Virus (HCV) Clinic, the first established clinic in the United States devoted to managing HCV infection in cancer patients.Lillian R. Roach, RN-BC, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Parag Mahale, MBBS, MPH, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Minas P. Economides, MD, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.The ideas and viewpoints expressed in this commentary are those of the author and do not necessarily represent any policy, position, or program of NCCN.Boris Blechacz, MD, PhD, is from the Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.Ethan Miller, MD, is from the Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.Roy Borchardt, PA-C, PhD, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Anis Rashid, MD, is from the Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, Texas.Thein H. Oo, MD, is from the Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.Bhavarth Shukla, MD, MPH, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Malik Farida, MD, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Charles D. Ericsson, MD, is from the Department of Internal Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, Texas.Bruno P. Granwehr, MD, MS, is from the Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.Issam I. Raad, MD, is Chairman, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • 1.

    AASLD/IDSA/IAS-USA. Recommendations for testing managing and treating hepatitis C. Available at http://www.hcvguidelines.org. Accessed February 26 2016.

    • Search Google Scholar
    • Export Citation
  • 2.

    TorresHAMahalePBlechaczB. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected populationJ Natl Compr Canc Netw2015;13:4150.

    • Search Google Scholar
    • Export Citation
  • 3.

    TorresHAAdachiJARoachLR. Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis2012;54:740742.

    • Search Google Scholar
    • Export Citation
  • 4.

    LocasciulliAAlbertiA. Hepatitis C virus serum markers and liver disease in children with leukemia. Leuk lymphoma1995;17:245249.

  • 5.

    TorresHAKasebAMahaleP. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series. J Hepatocellular Carcinoma2014;1:109114.

    • Search Google Scholar
    • Export Citation
  • 6.

    MahalePKontoyiannisDPChemalyRF. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol2012;57:11771185.

    • Search Google Scholar
    • Export Citation
  • 7.

    BorchardtRATorresHA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol2014;20:27712776.

  • 8.

    Peveling-OberhagJArcainiLHansmannMLZeuzemS. Hepatitis C-associated B-cell non-Hodgkin lymphomas: epidemiology, molecular signature and clinical management. J Hepatol2013;59:169177.

    • Search Google Scholar
    • Export Citation
  • 9.

    ArcainiLVallisaDRattottiS. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol2014;25:14041410.

    • Search Google Scholar
    • Export Citation
  • 10.

    KyvernitakisAMahalePPopatUR. Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents. Biol Blood Marrow Transplant2016;22:717722.

    • Search Google Scholar
    • Export Citation
  • 11.

    KlingemannHGGriggAPWilkie-BoydK. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse. Blood1991;78:33063311.

    • Search Google Scholar
    • Export Citation
  • 12.

    TorresHAMcDonaldGB. How we treat hepatitis C virus infection in patients with hematologic malignancies[published online ahead of print]. Bloodpii: blood-2016-05-718643.

    • Search Google Scholar
    • Export Citation
  • 13.

    TorresHAChongPPDe LimaM. Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations. Biol Blood Marrow Transplant2015;21:18701882.

    • Search Google Scholar
    • Export Citation
  • 14.

    AroraSThorntonKMurataG. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med2011;364:21992207.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 43 43 4
PDF Downloads 19 19 3
EPUB Downloads 0 0 0